Skip to main content
. 2020 Jun 4;11(6):420. doi: 10.1038/s41419-020-2629-3

Fig. 1. The expression of HOXA5 is down-regulated in cervical carcinomas.

Fig. 1

a Immunohistochemical staining of HOXA5 in clinical samples, including normal cervix (NC, n = 42), high-grade squamous intraepithelial lesion (HSIL, n = 28), and cervical carcinomas (CC, n = 55), original magnification, 1000×. b The immunohistochemical staining intensity was classified into negative, weak positive, and strong positive, and the percentage of each group was shown. c The scatter plots showed the IHC scores obtained for the staining of HOXA5 in different cervix lesion samples (points represent the IHC score per specimen, Student’s t-test is performed). d HOXA5 expression was detected by western blot in eight normal cervix samples and eight cervical carcinoma samples. GAPDH was used as loading control. e The quantitative illustration of the levels of HOXA5 protein using densitometry to measure the density of the corresponding bands in (d). Student’s t-test was carried out. f The HOXA5 mRNA expression level of clinical cervical cancer samples and normal cervix samples, data were obtained from GEO database. *p < 0.05, **p < 0.01, ***p < 0.001.